Method for manufacturing a single-phase pharmaceutical preparation for oral treatment to regulate blood pressure

摘要

Preparing a single phase pharmaceutical preparation for the oral therapy of the regulation of the blood pressure, using a contraceptive combination with 2 mg of dienogest and 0.030 mg of ethinylestradiol; or 2 mg of dienogest and 0.020 mg of ethinylestradiol; or 2 mg of dienogest and 0.015 mg of ethinylestradiol; or 1.5 mg of dienogest and 0.015 mg of ethinylestradiol to at least 21 day dose units, is claimed. An independent claim is included for a kit comprising at least 21 daily dose units of the contraceptive combination together with one or more auxiliary materials/carriers and maximally 7 daily intake-free or placebo-containing dose units. ACTIVITY : Hypotensive. MECHANISM OF ACTION : None given.